应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01228 北海康成-B
未开盘 05-06 16:08:49
0.445
-0.005
-1.11%
最高
0.465
最低
0.425
成交量
4.70万
今开
0.450
昨收
0.450
日振幅
8.89%
总市值
1.89亿
流通市值
1.89亿
总股本
4.25亿
成交额
2.08万
换手率
0.01%
流通股本
4.25亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
北海康成-B盘中异动 早盘快速下挫5.76%
自选股智能写手 · 05-06 09:47
北海康成-B盘中异动 早盘快速下挫5.76%
北海康成-B盘中异动 大幅拉升6.05%报0.456港元
自选股智能写手 · 05-02
北海康成-B盘中异动 大幅拉升6.05%报0.456港元
北海康成-B:2023年度收益增长30.3%,年内亏损减少21.7%
金融界港股 · 04-30
北海康成-B:2023年度收益增长30.3%,年内亏损减少21.7%
北海康成-B盘中异动 股价大涨9.88%报0.456港元
自选股智能写手 · 04-30
北海康成-B盘中异动 股价大涨9.88%报0.456港元
北海康成-B盘中异动 快速下跌6.95%报0.415港元
自选股智能写手 · 04-29
北海康成-B盘中异动 快速下跌6.95%报0.415港元
北海康成-B股价上涨24.92% 市值涨4248.5万港元
自选股智能写手 · 04-23
北海康成-B股价上涨24.92% 市值涨4248.5万港元
北海康成-B(01228)终止CAN008研发:资金转向加速海芮思及迈芮倍商业化和临床开发
和讯网 · 04-23
北海康成-B(01228)终止CAN008研发:资金转向加速海芮思及迈芮倍商业化和临床开发
北海康成-B(01228)决定终止CAN008在胶质母细胞瘤领域的研发及进一步试验
智通财经 · 04-22
北海康成-B(01228)决定终止CAN008在胶质母细胞瘤领域的研发及进一步试验
北海康成-B(01228)授出270万份购股权及270万份受限制股份单位
智通财经 · 04-09
北海康成-B(01228)授出270万份购股权及270万份受限制股份单位
北海康成(01228)发布截至2023年12月31日止年度业绩公告
金吾财讯 · 04-02
北海康成(01228)发布截至2023年12月31日止年度业绩公告
《公司业绩》北海康成(01228.HK)全年亏损收窄至3.79亿人民币
阿斯达克财经 · 04-01
《公司业绩》北海康成(01228.HK)全年亏损收窄至3.79亿人民币
北海康成-B(01228)发布年度业绩,股东应占亏损3.79亿元,同比收窄21.64%
智通财经 · 03-29
北海康成-B(01228)发布年度业绩,股东应占亏损3.79亿元,同比收窄21.64%
北海康成-B股价重挫12.46% 市值跌1486.88万港元
自选股智能写手 · 03-22
北海康成-B股价重挫12.46% 市值跌1486.88万港元
北海康成-B(01228)股价下跌6.061%,现价港币$0.31
阿斯达克财经 · 03-20
北海康成-B(01228)股价下跌6.061%,现价港币$0.31
北海康成-B盘中异动 早盘急速跳水6.34%报0.310港元
自选股智能写手 · 03-20
北海康成-B盘中异动 早盘急速跳水6.34%报0.310港元
北海康成-B(01228.HK)拟3月28日举行董事会会议批准全年业绩
格隆汇资讯 · 03-18
北海康成-B(01228.HK)拟3月28日举行董事会会议批准全年业绩
北海康成-B盘中异动 股价大跌7.85%报0.305港元
自选股智能写手 · 03-18
北海康成-B盘中异动 股价大跌7.85%报0.305港元
北海康成-B(01228)股价下跌9.231%,现价港币$0.295
阿斯达克财经 · 03-12
北海康成-B(01228)股价下跌9.231%,现价港币$0.295
北海康成-B盘中异动 股价大涨5.83%报0.345港元
自选股智能写手 · 03-12
北海康成-B盘中异动 股价大涨5.83%报0.345港元
北海康成-B盘中异动 快速拉升7.00%
自选股智能写手 · 03-11
北海康成-B盘中异动 快速拉升7.00%
暂无数据
公司概况
公司名称:
北海康成-B
所属市场:
SEHK
上市日期:
--
主营业务:
北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。该公司的主营业务是医疗产品的开发、生产、推广及销售。该公司的主要产品是用于治疗胶质母细胞瘤(GBM)的糖基化融合蛋白CAN008。该公司的产品主要用于亨特氏综合症(MPS II)等罕见病、罕见肿瘤等领域。该公司还从事基因疗法的开发。
发行价格:
--
{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":0.445,"timestamp":1714982929012,"preClose":0.45,"halted":0,"volume":47000,"delay":0,"floatShares":424838320,"shares":424838320,"eps":-0.9673568,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.005,"latestTime":"05-06 16:08:49","open":0.45,"high":0.465,"low":0.425,"amount":20815,"amplitude":0.088889,"askPrice":0.45,"askSize":15000,"bidPrice":0.425,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.9673567800046902,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715045400000},"adr":0,"listingDate":1639065600000,"adjPreClose":0.45,"openAndCloseTimeList":[[1714959000000,1714968000000],[1714971600000,1714982400000]],"volumeRatio":0.234297,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228/tweets","defaultTab":"tweets","newsList":[{"id":"2433464053","title":"北海康成-B盘中异动 早盘快速下挫5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433464053","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433464053?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:47","pubTimestamp":1714960037,"startTime":"0","endTime":"0","summary":"2024年05月06日早盘09时47分,北海康成-B股票出现波动,股价大幅下跌5.76%。截至发稿,该股报0.425港元/股,成交量2.1万股,换手率0.00%,振幅5.56%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。北海康成-B股票所在的生物技术行业中,整体涨幅为0.31%。北海康成-B公司简介:北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506094717861eb05b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506094717861eb05b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432695388","title":"北海康成-B盘中异动 大幅拉升6.05%报0.456港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432695388","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432695388?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:47","pubTimestamp":1714614470,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘09时47分,北海康成-B股票出现异动,股价大幅拉升6.05%。北海康成-B股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,科笛-B、北海康成-B、加科思-B涨幅较大,振幅较大的相关个股有科笛-B、创胜集团-B、基石药业-B,振幅分别为6.69%、6.08%、5.68%。该信息摘要如下:北海康成-B发布2023年度报告,报告显示,公司2023年度收益为人民币102.9百万元,相比2022年度的人民币79.0百万元增长30.3%,主要由于海芮思。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050209475087e8541d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050209475087e8541d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431333085","title":"北海康成-B:2023年度收益增长30.3%,年内亏损减少21.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431333085","media":"金融界港股","top":-1,"share":"https://www.laohu8.com/m/news/2431333085?lang=zh_cn&edition=full","pubTime":"2024-04-30 12:07","pubTimestamp":1714450025,"startTime":"0","endTime":"0","summary":"金融界4月30日消息,北海康成-B发布2023年度报告,报告显示,公司2023年度收益为人民币102.9百万元,相比2022年度的人民币79.0百万元增长30.3%,主要由于海芮思®及迈芮倍®的销售额增加。研发开支为人民币257.2百万元,相比2022年度的人民币311.2百万元减少17.4%。年内亏损为人民币378.8百万元,相比2022年度的人民币483.5百万元减少21.7%,主要由于收益增加以及研发开支及行政开支减少所致。\n\n\r\n 责任编辑:栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/30120740488644.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431802854","title":"北海康成-B盘中异动 股价大涨9.88%报0.456港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431802854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431802854?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:32","pubTimestamp":1714440750,"startTime":"0","endTime":"0","summary":"2024年04月30日早盘09时32分,北海康成-B股票出现波动,股价大幅拉升9.88%。截至发稿,该股报0.456港元/股,成交量0股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出0港元。北海康成-B股票所在的生物技术行业中,整体涨幅为0.94%。其相关个股中,科笛-B、北海康成-B、君实生物涨幅较大,振幅较大的相关个股有科笛-B、科伦博泰生物-B、泰格医药,振幅分别为13.64%、5.96%、4.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009323087e84d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009323087e84d2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431347009","title":"北海康成-B盘中异动 快速下跌6.95%报0.415港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431347009","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431347009?lang=zh_cn&edition=full","pubTime":"2024-04-29 15:26","pubTimestamp":1714375580,"startTime":"0","endTime":"0","summary":"2024年04月29日下午盘15时26分,北海康成-B股票出现异动,股价急速跳水6.95%。截至发稿,该股报0.415港元/股,成交量76.5万股,换手率0.18%,振幅10.11%。资金方面,该股资金流入5.8475万港元,流出27.861万港元。北海康成-B股票所在的生物技术行业中,整体涨幅为0.74%。北海康成-B公司简介:北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291526207924b814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291526207924b814&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429844001","title":"北海康成-B股价上涨24.92% 市值涨4248.5万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429844001","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429844001?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:33","pubTimestamp":1713836030,"startTime":"0","endTime":"0","summary":"2024年04月23日早盘09时33分,北海康成-B股票出现异动,股价大幅拉升24.92%。截至发稿,该股报0.401港元/股,成交量0股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出0港元。北海康成-B股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,北海康成-B、药明合联、康希诺生物涨幅较大,振幅较大的相关个股有药明合联、巨子生物、复宏汉霖,振幅分别为4.80%、3.47%、2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423093350861e7ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423093350861e7ed3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429900035","title":"北海康成-B(01228)终止CAN008研发:资金转向加速海芮思及迈芮倍商业化和临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2429900035","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2429900035?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:10","pubTimestamp":1713805830,"startTime":"0","endTime":"0","summary":"北海康成-B 【在临床试验未显著提升疗效后,北海康成-B决定终止CAN008在胶质母细胞瘤领域的研发】 北海康成-B公布了CAN008II期临床试验的顶线数据,该药物在治疗新诊断胶质母细胞瘤患者的试验中,并未在无进展生存期或总生存期方面提供额外的益处。公司经过深入评估,决定停止CAN008在胶质母细胞瘤领域的进一步开发与试验。公司表示,停止开发CAN008将释放资金,用于推进其他正在开发的项目,包括已获批产品海芮思和迈芮倍的商业化,以及CAN106、CAN103等项目的临床试验。北海康成-B强调,此举不会对集团整体业绩产生显著影响,同时有助于优化研发资源,提升运营效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042306575987a30240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042306575987a30240&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429920729","title":"北海康成-B(01228)决定终止CAN008在胶质母细胞瘤领域的研发及进一步试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2429920729","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429920729?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:56","pubTimestamp":1713797810,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B 公布,根据治疗新诊断胶质母细胞瘤患者的 CAN008 II期临床试验的顶线数据,在接受替莫唑胺及放疗的标准治疗的患者中,CAN008在无进展生存期或总生存期方面并无比安慰剂提供额外的裨益。经过慎重考虑,公司决定终止CAN008在胶质母细胞瘤领域的研发及进一步试验。停止在胶质母细胞瘤领域开发CAN008将不会对集团的业绩产生重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107241.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426070197","title":"北海康成-B(01228)授出270万份购股权及270万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2426070197","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426070197?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:58","pubTimestamp":1712671082,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B(01228)发布公告,于2024年4月9日,公司根据首次公开发售后购股权计划向两名购股权承授人授出合共270万份购股权及根据首次公开发售后受限制股份单位计划向两名受限制股份单位承授人授出合共270万份受限制股份单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100303.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424091877","title":"北海康成(01228)发布截至2023年12月31日止年度业绩公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2424091877","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2424091877?lang=zh_cn&edition=full","pubTime":"2024-04-02 18:09","pubTimestamp":1712052589,"startTime":"0","endTime":"0","summary":"公司于今日发布了截至2023年12月31日的财务状况和公司动态。财务要点l收益由截至2022年12月31日止年度的人民币79.0百万元增加人民币23.9百万元或30.3%至截至2023年12月31日止年度的人民币102.9百万元,主要由于海芮思及迈芮倍的销售额增加。l年内经调整亏损由截至2022年12月31日止年度的人民币456.7百万元减少约人民币97.8百万元或21.4%至截至2023年12月31日止年度的人民币358.9百万元。新患者识别加速,截至2023年12月31日已识别757例。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1934369","is_publish_highlight":false,"gpt_icon":0},{"id":"2424745704","title":"《公司业绩》北海康成(01228.HK)全年亏损收窄至3.79亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2424745704","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424745704?lang=zh_cn&edition=full","pubTime":"2024-04-01 22:30","pubTimestamp":1711981800,"startTime":"0","endTime":"0","summary":"北海康成-B(01228.HK) 公布2023年止年度业绩,收益录得1.03亿人民币(下同),按年增加30.3%。亏损由上年度4.83亿元,收窄至3.79亿元,每股亏损89分。不派末期息。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/28末期业绩无派息2023/08/31中期业绩无派息2023/03/31末期业绩无派息 2022/08/24中期业绩无派息 AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220106153102273_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220106153102273_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1338888/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2423110717","title":"北海康成-B(01228)发布年度业绩,股东应占亏损3.79亿元,同比收窄21.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423110717","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2423110717?lang=zh_cn&edition=full","pubTime":"2024-03-29 00:44","pubTimestamp":1711644299,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B 发布截至2023年12月31日止年度业绩,收益1.03亿元,同比增长30.26%;研发开支2.57亿元,同比减少17.34%;母公司拥有人应占亏损3.79亿元,同比收窄21.64%;每股亏损0.89元。据悉,收入增长主要由于海芮思及迈芮倍的销售额增加。由于宏观环境充满挑战,包括资本市场动荡和生物科技行业融资受限,北海康成已进一步确定关键项目的优先次序,该等项目将在来年实现重大开发和监管里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1095724.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421867448","title":"北海康成-B股价重挫12.46% 市值跌1486.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421867448","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421867448?lang=zh_cn&edition=full","pubTime":"2024-03-22 09:35","pubTimestamp":1711071304,"startTime":"0","endTime":"0","summary":"2024年03月22日早盘09时35分,北海康成-B股票出现波动,股价急速下挫12.46%。截至发稿,该股报0.281港元/股,成交量3000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出840港元。北海康成-B股票所在的生物技术行业中,整体跌幅为0.61%。其相关个股中,荃信生物-B、乐普生物-B、科笛-B涨幅较大,振幅较大的相关个股有药明巨诺-B、嘉和生物-B、圣诺医药-B,振幅分别为11.33%、6.78%、5.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220935047a4e5c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220935047a4e5c58&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420775152","title":"北海康成-B(01228)股价下跌6.061%,现价港币$0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2420775152","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420775152?lang=zh_cn&edition=full","pubTime":"2024-03-20 10:50","pubTimestamp":1710903000,"startTime":"0","endTime":"0","summary":"[下跌股]北海康成-B(01228) 股价在上午10:50比前收市价下跌6.061%,现股价为港币$0.31。至目前为止,今日最高价为$0.32,而最低价为$0.31。总成交量为8000股,总成交金额为港币$2510。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240320779/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2420683751","title":"北海康成-B盘中异动 早盘急速跳水6.34%报0.310港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420683751","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420683751?lang=zh_cn&edition=full","pubTime":"2024-03-20 10:46","pubTimestamp":1710902794,"startTime":"0","endTime":"0","summary":"2024年03月20日早盘10时46分,北海康成-B股票出现波动,股价快速下跌6.34%。截至发稿,该股报0.310港元/股,成交量3000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入960港元,流出0港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。北海康成-B股票所在的生物技术行业中,整体涨幅为0.43%。北海康成-B公司简介:北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320104634861df9ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320104634861df9ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420476974","title":"北海康成-B(01228.HK)拟3月28日举行董事会会议批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2420476974","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2420476974?lang=zh_cn&edition=full","pubTime":"2024-03-18 16:56","pubTimestamp":1710752176,"startTime":"0","endTime":"0","summary":"格隆汇3月18日丨北海康成-B(01228.HK)宣布,公司将于2024年3月28日(星期四)举行董事会会议,藉以(其中包括)考虑并批准公司及其附属公司截至2023年12月31日止年度业绩及其发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181656288b426419&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181656288b426419&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420586416","title":"北海康成-B盘中异动 股价大跌7.85%报0.305港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420586416","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420586416?lang=zh_cn&edition=full","pubTime":"2024-03-18 13:07","pubTimestamp":1710738475,"startTime":"0","endTime":"0","summary":"2024年03月18日下午盘13时07分,北海康成-B股票出现异动,股价急速下跌7.85%。截至发稿,该股报0.305港元/股,成交量1.5万股,换手率0.00%,振幅7.58%。资金方面,该股资金流入1650港元,流出3050港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。北海康成-B股票所在的生物技术行业中,整体跌幅为0.38%。北海康成-B公司简介:北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318130755791b16fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318130755791b16fc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418703623","title":"北海康成-B(01228)股价下跌9.231%,现价港币$0.295","url":"https://stock-news.laohu8.com/highlight/detail?id=2418703623","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2418703623?lang=zh_cn&edition=full","pubTime":"2024-03-12 14:35","pubTimestamp":1710225300,"startTime":"0","endTime":"0","summary":"[下跌股]北海康成-B(01228) 股价在下午02:35比前收市价下跌9.231%,现股价为港币$0.295。至目前为止,今日最高价为$0.345,而最低价为$0.295。总成交量为4万股,总成交金额为港币$1.23万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403123684/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2418324836","title":"北海康成-B盘中异动 股价大涨5.83%报0.345港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418324836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418324836?lang=zh_cn&edition=full","pubTime":"2024-03-12 11:13","pubTimestamp":1710213186,"startTime":"0","endTime":"0","summary":"2024年03月12日早盘11时13分,北海康成-B股票出现波动,股价快速上涨5.83%。截至发稿,该股报0.345港元/股,成交量10000股,换手率0.00%,振幅6.15%。资金方面,该股资金流入3270港元,流出0港元。北海康成-B股票所在的生物技术行业中,整体涨幅为1.44%。其相关个股中,嘉和生物-B、欧康维视生物-B、歌礼制药-B涨幅较大,振幅较大的相关个股有来凯医药-B、宜明昂科-B、基石药业-B,振幅分别为18.58%、14.60%、11.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031211130687e780e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031211130687e780e0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418710908","title":"北海康成-B盘中异动 快速拉升7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418710908","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418710908?lang=zh_cn&edition=full","pubTime":"2024-03-11 10:05","pubTimestamp":1710122724,"startTime":"0","endTime":"0","summary":"2024年03月11日早盘10时05分,北海康成-B股票出现异动,股价急速拉升7.00%。截至发稿,该股报0.321港元/股,成交量2.6万股,换手率0.01%,振幅5.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。北海康成-B股票所在的生物技术行业中,整体跌幅为0.18%。北海康成-B公司简介:北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311100524861dcda9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311100524861dcda9&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":0.0723},{"period":"1month","weight":0.4833},{"period":"3month","weight":0.0854},{"period":"6month","weight":-0.6844},{"period":"1year","weight":-0.7033},{"period":"ytd","weight":-0.5505}],"compareEarnings":[{"period":"1week","weight":0.0468},{"period":"1month","weight":0.1109},{"period":"3month","weight":0.1513},{"period":"6month","weight":0.0575},{"period":"1year","weight":-0.0734},{"period":"ytd","weight":0.0898}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。该公司的主营业务是医疗产品的开发、生产、推广及销售。该公司的主要产品是用于治疗胶质母细胞瘤(GBM)的糖基化融合蛋白CAN008。该公司的产品主要用于亨特氏综合症(MPS II)等罕见病、罕见肿瘤等领域。该公司还从事基因疗法的开发。","exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}